IDiyas

For the Inventor, By the Inventor

Danbury, CT, United States of America

Suresh R Kapadia

USPTO Granted Patents = 18


 

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 231(Granted Patents)


Company Filing History:

goldMedal11 out of 276 
 
Boehringer Ingelheim Pharmaceuticals, Inc.
 patents
silverMedal7 out of 1,535 
 
Boehringer Ingelheim International Gmbh
 patents

Years Active: 1998-2016

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):
1. 9376409 - Methods for making oxetan-3-ylmethanamines (2016-06-28),
2. 8946203 - Benzodioxane inhibitors of leukotriene production (2015-02-03),
3. 8222369 - Process for preparing macrocyclic compounds (2012-07-17),
4. 8101765 - Process for preparing acyclic HCV protease inhibitors (2012-01-24),
5. 8017771 - Process for preparing acyclic HCV protease inhibitors (2011-09-13),
6. 7608614 - Process for preparing macrocyclic compounds (2009-10-27),
7. 7514557 - Process for preparing acyclic HCV protease inhibitors (2009-04-07),
8. 7186827 - Dipeptide synthesis (2007-03-06),
9. 6703525 - Sulfonamide intermediates and methods of producing same (2004-03-09),
10. 6635767 - Synthesis of heteroarylamine intermediate compounds (2003-10-21),
11. 6613909 - Synthesis of heteroarylamine intermediate compounds (2003-09-02),
12. 6603000 - Synthesis for heteroarylamine compounds (2003-08-05),
13. 6593471 - Synthesis of heteroarylamine intermediate compounds (2003-07-15),
14. 6590099 - Synthesis of heteroarylamine intermediate compounds (2003-07-08),
15. 6492529 - Bis pyrazole-1H-pyrazole intermediates and their synthesis (2002-12-10),

Title: Suresh R Kapadia: Innovator in Pharmaceutical Chemistry

Introduction

Suresh R Kapadia is a distinguished inventor based in Danbury, CT (US). He holds a total of 18 patents that reflect his significant contributions to the field of pharmaceutical chemistry. His work primarily focuses on developing innovative methods and compounds that have practical applications in medicine.

Latest Patents

Among his latest patents, one notable invention is the "Methods for making oxetan-3-ylmethanamines." This invention relates to methods for synthesizing oxetan-3-ylmethanamines, which are characterized by the formula (I), where R1 and R2 are defined within the patent. The methods described in this patent enable the production of these compounds in high yields, making them suitable for large-scale commercial production.

Another significant patent is for "Benzodioxane inhibitors of leukotriene production." This invention pertains to compounds of formula (I), where R, A, X, and n are defined in the documentation. These compounds serve as inhibitors of leukotriene Ahydrolase (LTA4H) and are useful in treating disorders related to LTA4H. The patent also covers pharmaceutical compositions that include these compounds, methods for their use in treating various diseases, and processes for their preparation.

Career Highlights

Suresh has had a notable career, working with prominent companies such as Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH. His experience in these organizations has allowed him to contribute significantly to pharmaceutical research and development.

Collaborations

Throughout his career, Suresh has collaborated with talented individuals, including Nathan K Yee and Jinhua Jeff Song. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Suresh R Kapadia is a remarkable inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His innovative patents and collaborations highlight his dedication to improving medical treatments and contributing to scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…